SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-13-002293
Filing Date
2013-10-31
Accepted
2013-10-31 17:22:26
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q medizone10q093013.htm 10-Q 392953
2 EX-31.1 ex31-1.htm EX-31.1 12614
3 EX-31.2 ex31-2.htm EX-31.2 11264
4 EX-32.1 ex32-1.htm EX-32.1 6488
5 EX-32.2 ex32-2.htm EX-32.2 6103
  Complete submission text file 0001185185-13-002293.txt   2626180

Data Files

Seq Description Document Type Size
6 EX-101.INS mzei-20130930.xml EX-101.INS 295414
7 EX-101.SCH mzei-20130930.xsd EX-101.SCH 32556
8 EX-101.CAL mzei-20130930_cal.xml EX-101.CAL 23217
9 EX-101.DEF mzei-20130930_def.xml EX-101.DEF 138195
10 EX-101.LAB mzei-20130930_lab.xml EX-101.LAB 231283
11 EX-101.PRE mzei-20130930_pre.xml EX-101.PRE 140988
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 131183695
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries